Patients controlling their own admissions to inpatient care
Official title: Patient-controlled Admissions to Inpatient Care for Patients With Severe Psychiatric Conditions in Region Stockholm
Run by Karolinska Institutet · NCT04862897 · Data updated 2026-11-12
This study tests whether letting patients with severe mental health issues decide when to go into the hospital can improve their control over their care and overall well-being.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 15 Years and up |
| Sex | All |
| Enrollment | 564 (estimated) |
| Sponsor | Karolinska Institutet Academic / other |
| Locations | 1 site (Stockholm, Stockholm County) |
| Status | Recruiting |
| Started | January 1, 2020 |
| Main results expected | August 31, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | September 16, 2025 |
| Trial ID | NCT04862897 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals with severe psychiatric conditions who have ongoing outpatient care and a history of inpatient treatment.
✕Probably not a fit
Patients who do not have the capacity to provide informed consent or those without a prior inpatient care history may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the implementation of patient-controlled admissions for individuals with severe psychiatric conditions in Region Stockholm, Sweden. It aims to empower patients by allowing them to admit themselves to inpatient care when needed, rather than relying solely on healthcare providers to make that decision. The approach is designed to enhance patient autonomy, reduce involuntary admissions, and improve overall quality of life. The study will involve patients who have ongoing contact with outpatient care and have previously required inpatient treatment.
Why it matters
Potential benefit: If successful, this approach could significantly enhance patient autonomy and reduce the need for involuntary psychiatric admissions.
How similar studies have gone: Previous smaller studies have shown positive outcomes for patient-controlled admissions, indicating potential for success in this larger implementation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have an on-going contact with outpatient care. * Have an individual care plan and crisis plan. * Have had at least one inpatient care period the previous year. * Are expected to have the greatest need of inpatient care. * Are interested in, and understand the concept of, patient-controlled admissions. Exclusion Criteria: * No informed consent to participate in the research project (concerns only self-reported outcomes). Matched control group: \- A matched control group consisting of seven times the number of of patients receiving patient-control admissions will be utilised for all primary outcome measures, other psychiatric or somatic healthcare consumption, sick-leave, and redeemed prescriptions (matched on account of age, gender, diagnosis, and history of psychiatric inpatient care, but who have not been granted access to patient-controlled admissions)
Where it's running
-
Centre for Psychiatry Research
Stockholm, Stockholm County, Sweden Recruiting
Study contacts
- Principal investigator: Alexander Rozental, PhD — Karolinska Institutet
- Study coordinator: Alexander Rozental, PhD
- Email: alexander.rozental@ki.se
- Phone: +46(0)736937948
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Imaging Mitochondrial Complex-I and Brain Metabolism in Alcohol Use Disorder
This study tests whether PET imaging with [18F]BCPP-EF and [18F]FDG can reveal differences in brain energy use between adults with alcohol use disorder and healthy controls, and whether these measures relate to relapse risk.
-
Vagustim taVNS: Testing a sham in adults for immune-related conditions
This small, double-blind study tests whether Vagustim taVNS’s sham method works as a believable placebo in healthy adults.
-
Imaging Brain Mitochondrial Complex-I in Cocaine Use Disorder
This study uses a PET scan with [F-18]BCPP-EF to see how mitochondrial Complex-I activity in the brain differs between people with cocaine use disorder and healthy controls.
-
Emotion regulation in people who experience repetitive negative thinking
This project will use harmless infrared brain imaging to see if people who habitually ruminate show different brain responses during emotion-regulation tasks compared with matched healthy adults.
-
Walking adaptability and foot tapping measurements in people with multiple sclerosis
This test compares the Walking Adaptability Ladder Test and Foot Tap Test in people with mild multiple sclerosis and matched healthy adults to see if they reliably detect subtle walking and motor changes.
-
Colored-light pain relief and brain mapping in chronic musculoskeletal pain
This trial will test whether showing different colored lights to the eyes can reduce pain and change brain activity in adults with chronic musculoskeletal pain compared with healthy, age- and sex-matched controls.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.